Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1280P is a pseudogene copy of the gene for U6 small nuclear RNA, generated through genomic duplication or retrotransposition events. Unlike the parental U6 small nuclear RNA gene, which encodes a critical RNA component of the spliceosome essential for pre-mRNA splicing, this pseudogene does not produce a functional RNA molecule and lacks biological activity. Pseudogenes such as RNU6-1280P are common in the human genome and are thought to arise through errors in gene duplication or retrotransposition mediated by LINE-1 (L1) elements. These sequences can serve as evolutionary footprints of genome dynamics but are not known to be expressed or to act as therapeutic or disease-relevant targets in their own right. In summary, RNU6-1280P is a non-functional genomic element, not a therapeutic or research target, with no known direct biological, pathological, or pharmacological role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1280, pseudogene (RNU6-1280P).